Giguère, C. M.; Bauman, N. M.; Sato, Y.; Burke, D. K.; Greinwald, J. H.; Pransky, S.; Kelley, P.; Georgeson, K.; Smith, R. J. (2002). „Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: A prospective multi-institutional trial”. Arch Otolaryngol Head Neck Surg. 128 (10): 1137—44. PMID12365884. S2CID6454956. doi:10.1001/archotol.128.10.1137..
Wheeler, Jonathan S.; Morreau, Phillip; Mahadevan, Murali; Pease, Percy (јул 2005). „OK‐432 and lymphatic malformations in children: The Starship Children's Hospital experience”. J Pediatr Surg. 40 (7): 855—858. PMID15456432. S2CID34746034. doi:10.1111/j.1445-1433.2004.03115.x.CS1 одржавање: Формат датума (веза)
Duman, L.; Karnak, I.; Akinci, D.; Tanyel, F. C. (јануар 2006). „Extensive cervical-mediastinal cystic lymphatic malformation treated with sclerotherapy in a child with Klippel-Trenaunay syndrome”. J Pediatr Surg. 41 (1): e21—4. PMID16410083. doi:10.1016/j.jpedsurg.2005.10.067.CS1 одржавање: Формат датума (веза)
Emran, M. A.; Dubois, J.; Laberge, L.; Al-Jazaeri, A.; Bütter, A.; Yazbeck, S. (2006). „Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children”. J Pediatr Surg. 41 (5): 975—9. PMID16677896. doi:10.1016/j.jpedsurg.2006.01.019..
Vézina, C.; Kudelski, A.; Sehgal, S. N. (1975). „Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle”. The Journal of Antibiotics. 28 (10): 721—726. PMID1102508. doi:10.7164/antibiotics.28.721.
Dekeuleneer, V.; Seront, E.; Van Damme, A.; Boon, L. M.; Vikkula, M. (2020). „Theranostic Advances in Vascular Malformations”. Journal of Investigative Dermatology. 140 (4): 756—763. PMID32200879. S2CID214616720. doi:10.1016/j.jid.2019.10.001..
Gedikbasi, A.; Gul, A.; Sargin, A.; Ceylan, Y. (2007). „Cystic hygroma and lymphangioma: Associated findings, perinatal outcome and prognostic factors in live-born infants”. Archives of Gynecology and Obstetrics. 276 (5): 491—498. PMID17429667. S2CID26084111. doi:10.1007/s00404-007-0364-y.
Shulman, L. P.; Emerson, D. S.; Felker, R. E.; Phillips, O. P.; Simpson, J. L.; Elias, S. (1992). „High frequency of cytogenetic abnormalities in fetuses with cystic hygroma diagnosed in the first trimester”. Obstetrics and Gynecology. 80 (1): 80—2. PMID1603503.
Giguère, C. M.; Bauman, N. M.; Sato, Y.; Burke, D. K.; Greinwald, J. H.; Pransky, S.; Kelley, P.; Georgeson, K.; Smith, R. J. (2002). „Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: A prospective multi-institutional trial”. Arch Otolaryngol Head Neck Surg. 128 (10): 1137—44. PMID12365884. S2CID6454956. doi:10.1001/archotol.128.10.1137..
Wheeler, Jonathan S.; Morreau, Phillip; Mahadevan, Murali; Pease, Percy (јул 2005). „OK‐432 and lymphatic malformations in children: The Starship Children's Hospital experience”. J Pediatr Surg. 40 (7): 855—858. PMID15456432. S2CID34746034. doi:10.1111/j.1445-1433.2004.03115.x.CS1 одржавање: Формат датума (веза)
Duman, L.; Karnak, I.; Akinci, D.; Tanyel, F. C. (јануар 2006). „Extensive cervical-mediastinal cystic lymphatic malformation treated with sclerotherapy in a child with Klippel-Trenaunay syndrome”. J Pediatr Surg. 41 (1): e21—4. PMID16410083. doi:10.1016/j.jpedsurg.2005.10.067.CS1 одржавање: Формат датума (веза)
Emran, M. A.; Dubois, J.; Laberge, L.; Al-Jazaeri, A.; Bütter, A.; Yazbeck, S. (2006). „Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children”. J Pediatr Surg. 41 (5): 975—9. PMID16677896. doi:10.1016/j.jpedsurg.2006.01.019..
Vézina, C.; Kudelski, A.; Sehgal, S. N. (1975). „Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle”. The Journal of Antibiotics. 28 (10): 721—726. PMID1102508. doi:10.7164/antibiotics.28.721.
Dekeuleneer, V.; Seront, E.; Van Damme, A.; Boon, L. M.; Vikkula, M. (2020). „Theranostic Advances in Vascular Malformations”. Journal of Investigative Dermatology. 140 (4): 756—763. PMID32200879. S2CID214616720. doi:10.1016/j.jid.2019.10.001..
Zheng, J. W.; Qin, Z. P.; Zhang, Z. Y. (децембар 2005). „Management of lymphatic malformations in oral and maxillofacial regions: The rationale according to the new classification”. Shanghai Kou Qiang Yi Xue. 14 (6): 553—6. PMID16400476.CS1 одржавање: Формат датума (веза).
Gedikbasi, A.; Gul, A.; Sargin, A.; Ceylan, Y. (2007). „Cystic hygroma and lymphangioma: Associated findings, perinatal outcome and prognostic factors in live-born infants”. Archives of Gynecology and Obstetrics. 276 (5): 491—498. PMID17429667. S2CID26084111. doi:10.1007/s00404-007-0364-y.
Giguère, C. M.; Bauman, N. M.; Sato, Y.; Burke, D. K.; Greinwald, J. H.; Pransky, S.; Kelley, P.; Georgeson, K.; Smith, R. J. (2002). „Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: A prospective multi-institutional trial”. Arch Otolaryngol Head Neck Surg. 128 (10): 1137—44. PMID12365884. S2CID6454956. doi:10.1001/archotol.128.10.1137..
Wheeler, Jonathan S.; Morreau, Phillip; Mahadevan, Murali; Pease, Percy (јул 2005). „OK‐432 and lymphatic malformations in children: The Starship Children's Hospital experience”. J Pediatr Surg. 40 (7): 855—858. PMID15456432. S2CID34746034. doi:10.1111/j.1445-1433.2004.03115.x.CS1 одржавање: Формат датума (веза)
Dekeuleneer, V.; Seront, E.; Van Damme, A.; Boon, L. M.; Vikkula, M. (2020). „Theranostic Advances in Vascular Malformations”. Journal of Investigative Dermatology. 140 (4): 756—763. PMID32200879. S2CID214616720. doi:10.1016/j.jid.2019.10.001..